Literature DB >> 31353118

Higher NAFLD fibrosis score is associated with impaired eGFR.

Meng-Hsuan Hsieh1, Kuan-Ta Wu2, Yi-Yu Chen2, Jeng-Fu Yang2, Wen-Yi Lin3, Ning-Chia Chang3, Chia-Yi Lin4, Chao-Kuan Huang3, Chao-Ling Wang5, Hung-Yi Chuang5, Shu-Ching Lin2, Yu-Kuei Hsu2, Yi-Shan Tsai6, Wan-Long Chuang7, Ming-Lung Yu8, Chia-Yen Dai9.   

Abstract

BACKGROUND/
PURPOSE: Chronic kidney disease (CKD) has become a worldwide health problem, leading to high morbidity and mortality, and non-alcoholic fatty liver disease (NAFLD) is considered a risk factor for CKD. The aim of this study was to explore the relationship between NAFLD fibrosis score (NFS) and the estimated glomerular filtration rate (eGFR), and identify possible risk factors related to the NFS among Taiwanese subjects.
METHODS: Subjects were enrolled from the database of the Department of Preventive Medicine of Kaohsiung Municipal Hsiao-Kang Hospital. The eGFR was calculated according to the Taiwanese Modification of Diet in Renal Disease (TMDRD) equation, and the NFS was employed to evaluate the fibrotic level.
RESULTS: In total, 11,376 subjects were enrolled in this study, with a mean age of 52.0 ± 6.81 years, including 4529 (39.8%) males. A fasting sugar level ≥100 mg/dL (OR = 1.70, 95% CI = 1.52-1.87) and an abnormal waist circumference (OR = 1.81, 95% CI = 1.65-1.99) were significant factors associated with NFS (p < 0.05). Trends of a decreasing TMDRD score and an increasing NFS with increasing age were noted (p < 0.05). The NFS was significantly negatively correlated with the TMDRD score (standard coefficients: -0.067, p < 0.001).
CONCLUSIONS: A higher NFS is associated with an impaired eGFR in Taiwanese subjects. Controlling risk factors, especially fasting sugar level and waist circumference, may be useful in preventing NFS deterioration, which is negatively correlated with the eGFR.
Copyright © 2019. Published by Elsevier B.V.

Entities:  

Keywords:  Estimated glomerular filtration rate; Fasting sugar; NAFLD fibrosis score; Waist circumference

Year:  2019        PMID: 31353118     DOI: 10.1016/j.jfma.2019.07.007

Source DB:  PubMed          Journal:  J Formos Med Assoc        ISSN: 0929-6646            Impact factor:   3.282


  3 in total

Review 1.  Non-alcoholic fatty liver and chronic kidney disease: Retrospect, introspect, and prospect.

Authors:  Rajiv Heda; Masahiko Yazawa; Michelle Shi; Madhu Bhaskaran; Fuad Zain Aloor; Paul J Thuluvath; Sanjaya K Satapathy
Journal:  World J Gastroenterol       Date:  2021-05-07       Impact factor: 5.742

Review 2.  Metabolic-associated Fatty Liver Disease (MAFLD): A Multi-systemic Disease Beyond the Liver.

Authors:  Eda Kaya; Yusuf Yilmaz
Journal:  J Clin Transl Hepatol       Date:  2021-10-19

3.  Study on the correlation between urinary retinol-binding protein and nonalcoholic fatty liver disease.

Authors:  Chuang Li; Weiwei Kong; Lixia Kang; Tiehan Zhang; Weiqun Zhang; Weidong Wang
Journal:  J Med Biochem       Date:  2021-01-26       Impact factor: 3.402

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.